Related references
Note: Only part of the references are listed.Changes in Cytomegalovirus Seroprevalence Among US Children Aged 1-5 Years: The National Health and Nutrition Examination Surveys
Molly R. Petersen et al.
CLINICAL INFECTIOUS DISEASES (2021)
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study
Jan Styczynski et al.
BONE MARROW TRANSPLANTATION (2021)
Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant
Anat Stern et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Alessandra Sperotto et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Hermann Einsele et al.
BLOOD (2020)
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation
Satoshi Kaito et al.
BLOOD ADVANCES (2020)
Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
Tang-Her Jaing et al.
MEDICINE (2019)
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
Sung-Yeon Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
Krzysztof Czyzewski et al.
ANNALS OF HEMATOLOGY (2019)
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution
Ricardo Melendez-Munoz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
The impact of alternative donor types on viral infections in pediatric hematopoietic stem cell transplantation
D. Atay et al.
PEDIATRIC TRANSPLANTATION (2018)
Cytomegalovirus resistance in CD34+-selected hematopoietic cell transplant recipients
Seong Jin Kim et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children
Ewelina Pukownik et al.
ANTICANCER RESEARCH (2018)
Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation
Jan Styczynski
INFECTIOUS DISEASES AND THERAPY (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients
Jhong-Lin Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2017)
Cytomegalovirus Treatment in Pediatric Hematopoietic Stem Cell Transplant Patients
Bethany A. Wattles et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report
Pooja Khandelwal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center
R. Grant Rowe et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation
Evelyn Rustia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia
Jiro Inagaki et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation
Yao-Ting Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation
Amit Kalra et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission
Jae-Ho Yoon et al.
ONCOTARGET (2016)
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
Margaret L. Green et al.
LANCET HAEMATOLOGY (2016)
T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells
R. J. O'Reilly et al.
BONE MARROW TRANSPLANTATION (2015)
The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients
Miriam Ciaurriz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
A Survey of Infectious Disease Clinical Practices Among Pediatric Blood and Marrow Transplant Programs in the United States
Hisham Abdel Azim et al.
PEDIATRIC BLOOD & CANCER (2015)
Seroprevalence of Cytomegalovirus among Children 1 to 5 Years of Age in the United States from the National Health and Nutrition Examination Survey of 2011 to 2012
Tatiana M. Lanzieri et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children
Mohamed Jeljeli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
Margaret L. Green et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004
Sheri Lewis Bate et al.
CLINICAL INFECTIOUS DISEASES (2010)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation
N. G. Almyroudis et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis
Minoo Battiwalla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant -: A retrospective study on the risk factors and the efficacy of treatment
SR Patel et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
M Boeckh et al.
BLOOD (2004)
Share Paper
